| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |